All news

22 MAR 2021

Approval of the General Meeting’s resolutions Solid cash position to continue development

The Combined General Meeting of Spineway’s shareholders was held upon first notice of meeting on Monday, 8 March 2020, behind closed doors, at the Company’s registered office. The number of shares held by the shareholders represented amounted to 3 232 993 768 shares, i.e., a turnout of 25.79%.

Press releases
22 MAR 2021

Exclusive negotiations for the acquisition of a start-up in the field of spinal surgery

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), announces that it has entered exclusive negotiations with a view to the acquisition of 100% of the capital of a European start-up specialized in the design, manufacture and sale of implants and instruments for spinal surgery.

Press releases
25 FEB 2021

Signature of a partnership with Tsunami Medical

Spineway announces the signature of a partnership with the Italian company Tsunami Medical, pioneer in innovative 3D-printed solutions, for the sale of Twin Peaks interbody cages produced with 3D printers.

Press releases
11 FEB 2021

Continued expansion in Asia

Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.

Press releases
28 JAN 2021

September 9 2020 Launch of MISTI, a modular platform for instruments

Spineway, specialized in the treatment of severe disorders of the spine, announces the launch of a new concept: MISTI (acronym for Minimally Invasive Spine Total Instrumentation).

Press releases
28 JAN 2021

April 23 2020 Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments

Spineway, specialist in designing innovative surgical implants and instruments for treating severe disorders of the spinal column, announces the signature of an exclusive agreement for the distribution of its products in Japan with MURANAKA Medical Instruments.

Press releases
28 JAN 2021

January 8 2021 2021 Financial calendar

SPINEWAY (ISIN : FR0011398874 – ALSPW), specialized in the treatment of severe disorders of the spine, announced today its 2021 financial calendar.

Press releases
28 JAN 2021

July 23 2020 Publication of a clinical study on the advantages of Mont-Blanc 3D+ in the treatment of scoliosis

Spineway, specialized in the treatment of severe disorders of the spine, announces the publication of a scientific article in the renowned scientific journal Spine Deformity1 highlighting the benefits of the Mont-Blanc 3D+ technology for the treatment of adolescent idiopathic scoliosis.

Press releases
28 JAN 2021

April 16 2020 2019 annual results

Spineway’s Board of Directors, at a meeting held on 15 April 2020 chaired by Stéphane Le Roux, closed the 2019 annual accounts. The Group’s Statutory Auditors have audited these accounts and their reports are being prepared.

Press releases
LOADING